Vivos Therapeutics, Inc. (VVOS) Net income 2019–2025
Vivos Therapeutics, Inc. (VVOS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$21.2MFY2025 · since FY2019: -$10.8M → -$21.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.2M | -90.1% |
| FY2024 | -$11.1M | +18.0% |
| FY2023 | -$13.6M | +43.0% |
| FY2022 | -$23.8M | -17.5% |
| FY2021 | -$20.3M | -68.3% |
| FY2020 | -$12.1M | -12.1% |
| FY2019 | -$10.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice